azacitidine has been researched along with Becker Muscular Dystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, J; Li, W; Peng, F; Shang, Y; Xiong, F; Zhang, C; Zhao, C | 1 |
| Kawamichi, Y; Saito, K; Umezawa, A | 1 |
1 review(s) available for azacitidine and Becker Muscular Dystrophy
| Article | Year |
|---|---|
[Cell fusion as a key mechanism for cell-based therapy towards Duchenne muscular dystrophy].
Topics: Animals; Azacitidine; Cell Differentiation; Cell Fusion; Cell Transplantation; Cell- and Tissue-Based Therapy; Disease Models, Animal; Dystrophin; Endometrium; Female; Humans; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Placenta; Pregnancy; Regenerative Medicine | 2012 |
1 other study(ies) available for azacitidine and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Inhibition of myostatin promotes myogenic differentiation of rat bone marrow-derived mesenchymal stromal cells.
Topics: Animals; Antibodies, Blocking; Antigens, Differentiation; Azacitidine; Bone Marrow; Cell Differentiation; Cells, Cultured; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Motor Activity; Muscle Development; Muscular Dystrophy, Duchenne; Myostatin; Rats; Rats, Sprague-Dawley; Stromal Cells | 2009 |